{"name": "Stemline Therapeutics",
 "permalink": "stemline-therapeutics",
 "crunchbase_url": "http://www.crunchbase.com/company/stemline-therapeutics",
 "homepage_url": "http://www.stemline.com",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": 2003,
 "founded_month": 8,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "stemline, stemline-therapeutics, cancer, cancer-stem-cells, leukemia, roots, care",
 "alias_list": "",
 "email_address": "info@stemline.com",
 "phone_number": "212-831-1111",
 "description": " Targeting cancer at its root",
 "created_at": "Fri Jun 05 10:49:05 UTC 2009",
 "updated_at": "Tue Apr 09 14:28:07 UTC 2013",
 "overview": "\u003Cp\u003EStemline Therapeutics, Inc. is a clinical stage biopharmaceutical company and a leading developer of novel oncology compounds directed to cancer stem cell targets. Stemline\u00e2\u20ac\u2122s lead compound, SL-401, targets the interleukin-3 receptor present on multiple hematological cancers including leukemia blasts and leukemia cancer stem cells. SL-401 has demonstrated single agent anti-tumor activity at tolerable doses in a multi-center Phase I human trial.\u003C/p\u003E\n\n\u003Cp\u003EBehind its lead, Stemline is developing a broad portfolio of compounds directed at this and other high value cancer stem cell targets of a variety of hematological and solid cancers. In addition, Stemline has built a robust discovery platform called \u00e2\u20ac\u0153StemScreen\u00c2\u00ae\u00e2\u20ac\u009d which the Company has utilized to identify multiple compounds that target and impair cancer stem cells.\u003C/p\u003E\n\n\u003Cp\u003EStemline also possesses a comprehensive intellectual property portfolio that includes the earliest filings in the cancer stem cell field covering cancer stem cell-directed therapeutics, diagnostics, and drug screening.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[101,
       40],
      "assets/images/resized/0004/6901/46901v1-max-150x150.png"],
     [[101,
       40],
      "assets/images/resized/0004/6901/46901v1-max-250x250.png"],
     [[101,
       40],
      "assets/images/resized/0004/6901/46901v1-max-450x450.png"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [{"is_past": false,
    "title": "CEO",
    "person":
     {"first_name": "Ivan",
      "last_name": "Bergstein",
      "permalink": "ivan-bergstein",
      "image": null}},
   {"is_past": false,
    "title": "Director of Operations",
    "person":
     {"first_name": "Thomas",
      "last_name": "P. Cirrito",
      "permalink": "thomas-p-cirrito",
      "image": null}}],
 "competitions":
  [{"competitor":
     {"name": "OncoMed Pharmaceuticals",
      "permalink": "oncomed-pharmaceuticals",
      "image":
       {"available_sizes":
         [[[150,
            46],
           "assets/images/resized/0008/4217/84217v1-max-150x150.jpg"],
          [[193,
            60],
           "assets/images/resized/0008/4217/84217v1-max-250x250.jpg"],
          [[193,
            60],
           "assets/images/resized/0008/4217/84217v1-max-450x450.jpg"]],
        "attribution": null}}}],
 "providerships":
  [],
 "total_money_raised": "$12.5M",
 "funding_rounds":
  [{"round_code": "a",
    "source_url": "",
    "source_description": "Capital Funding Report",
    "raised_amount": 12500000.0,
    "raised_currency_code": "USD",
    "funded_year": 2008,
    "funded_month": 4,
    "funded_day": 9,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "Pequot Capital",
         "permalink": "pequot-capital",
         "image":
          {"available_sizes":
            [[[150,
               55],
              "assets/images/resized/0002/9564/29564v1-max-150x150.png"],
             [[250,
               93],
              "assets/images/resized/0002/9564/29564v1-max-250x250.png"],
             [[252,
               94],
              "assets/images/resized/0002/9564/29564v1-max-450x450.png"]],
           "attribution": null}},
       "person": null}]}],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "",
    "address1": "1675 York Avenue ",
    "address2": "Suite 30-E",
    "zip_code": "10128",
    "city": "New York",
    "state_code": "NY",
    "country_code": "USA",
    "latitude": 40.7775647,
    "longitude": -73.9459335}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [{"available_sizes":
     [[[150,
        80],
       "assets/images/resized/0004/6900/46900v1-max-150x150.jpg"],
      [[250,
        134],
       "assets/images/resized/0004/6900/46900v1-max-250x250.jpg"],
      [[450,
        242],
       "assets/images/resized/0004/6900/46900v1-max-450x450.jpg"]],
    "attribution": null}],
 "external_links":
  []}